Welcome to our dedicated page for Astrotech news (Ticker: ASTC), a resource for investors and traders seeking the latest updates and insights on Astrotech stock.
Astrotech Corp (ASTC) delivers cutting-edge solutions in chemical analysis and mass spectrometry through its 1st Detect and AgLAB divisions. This news hub provides investors and industry professionals with timely updates on technological advancements, strategic partnerships, and operational developments shaping security, agriculture, and analytical instrumentation markets.
Access official press releases, earnings reports, and market analyses in one centralized location. Track updates on trace detection systems for security applications, mass spectrometry innovations for agricultural optimization, and cross-industry collaborations driving ASTC's growth.
Our curated news collection covers:
- Product launch announcements
- Financial performance updates
- Research & development milestones
- Strategic partnership disclosures
- Industry recognition and patents
Bookmark this page for streamlined monitoring of ASTC's progress in commercializing scientific innovations. Verify timestamps on all materials and consult original SEC filings for complete disclosure details.
Astrotech (NASDAQ:ASTC) reported its fiscal year 2025 results, showing a decrease in revenue to $1.0 million due to lower device sales at its 1st Detect subsidiary. The company maintained a slight improvement in gross margin at 45.3% compared to 45.1% in the previous year.
Key developments include the formation of EN-SCAN, a new subsidiary for environmental testing, the launch of an enhanced TRACER 1000 Narcotics Trace Detector, and securing a DHS research contract. The TRACER 1000 is now deployed in 34 locations across 16 countries. The company maintains a strong financial position with $18.2 million in cash and investments as of June 30, 2025.
Astrotech Corporation (NASDAQ: ASTC) has appointed Nihanth Badugu as its new Chief Operating Officer, effective August 13, 2025. Badugu, 37, previously served as Astrotech's Director of Program Management since August 2023, where he led initiatives to enhance operational efficiency.
Prior to joining Astrotech, Badugu held positions at Thermo Fisher Scientific as NPI Program Manager (2020-2023), where he led COVID-19 diagnostic products launches, and served as Senior Program Manager at PVA Consulting Group (2017-2020). He holds a Bachelor of Science degree from York University.
Astrotech (NASDAQ: ASTC) has launched its new EN-SCAN product line of portable environmental testing instruments, featuring proprietary ATi Gas Chromatograph Column and Mass Spectrometer Technology. The product lineup includes three solutions: EN-SCAN Rugged-Lab GC-MS, EN-SCAN Fenceline Monitor, and EN-SCAN Handheld GC.
The technology enables real-time environmental monitoring for air, water, and soil analysis, delivering instant results compared to traditional methods that require lab testing and lengthy wait times. EN-SCAN devices come preloaded with thousands of chemical signatures and support applications in environmental compliance, refining, manufacturing, emergency response, and industrial hygiene.
Astrotech (NASDAQ:ASTC) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The company's leadership team, including Chairman and CEO Thomas B. Pickens III and CFO Jennifer Cañas, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel in New York City.
Interested investors can schedule meetings through their H.C. Wainwright representative or by contacting Astrotech's Investor Relations directly.
Astrotech Corporation (NASDAQ: ASTC) announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector in Vietnam through its subsidiary 1st Detect. This expansion into Southeast Asia represents a strategic milestone in the company's global growth.
The TRACER 1000 NTD™ system, which utilizes Mass Spectrometry technology, provides confirmatory trace narcotics detection with near-zero false alarm rates. CEO Tom Pickens highlighted that the global narcotics and explosives trace detection market is valued at over $7 billion and is experiencing rapid growth due to increasing demand for innovative security solutions.
Astrotech Corporation (NASDAQ: ASTC) has appointed Jennifer Cañas as its new Chief Financial Officer, effective May 22, 2025. Cañas, who has served as the Company's Corporate Controller since June 2022, brings over 20 years of senior financial experience to the role. Prior to joining Astrotech, she was Controller at The Texas Water Company (2018-2022) and founded a tax and financial advisory firm. She also has experience at PricewaterhouseCoopers and other accounting firms.
A Certified Public Accountant, Cañas graduated with honors from the University of Houston – Clear Lake with a BS in accounting. She is actively involved in community service through Big Brothers Big Sisters and Financial Peace University. Chairman and CEO Thomas B. Pickens III praised Cañas' leadership and competence, expressing confidence in her ability to deliver value for shareholders.
Astrotech (NASDAQ: ASTC) reported its Q3 FY2025 financial results, showing significant revenue growth to $534,000 compared to $50,000 in Q3 FY2024. The revenue came from TRACER 1000™ shipments, a government grant, and recurring sales. The company maintains a strong balance sheet with $20.9 million in cash and investments, down from $31.9 million in June 2024.
Key developments include a DHS R&D contract for the TRACER 1000, a $429,000 purchase order from Intuitive Research, the creation of EN-SCAN subsidiary for environmental testing, and the configuration of TRACER 1000 NTD for synthetic opiate detection. The company's mass spectrometry instruments are now deployed in 15 countries for explosive trace detection, with expanded applications in narcotics detection, environmental monitoring, and chemical processing.
["Revenue increased significantly to $534,000 in Q3 FY2025 from $50,000 in Q3 FY2024", "Secured DHS R&D contract for TRACER 1000 development", "Received $429,000 purchase order from TSA contractor", "Strong balance sheet with $20.9 million in cash and investments", "Expanded market presence with products deployed in 15 countries"]Astrotech (ASTC) has announced the launch of an enhanced version of its TRACER 1000™ Narcotics Trace Detector through its 1st Detect subsidiary. The upgraded device is specifically designed to detect synthetic opiates and novel psychoactive substances (NPS).
The enhanced TRACER 1000 NTD utilizes advanced mass spectrometry technology to identify minute traces of illicit substances, including fentanyl analogs and emerging synthetic drugs. Key features include:
- Full-spectrum screening capabilities
- High precision and sensitivity detection
- Rapid analysis with results in seconds
- User-friendly interface with minimal training requirements
According to Thomas B. Pickens, III, Chairman and CEO of 1st Detect, this launch represents significant progress in combating synthetic opiates and NPS. The device is now available for deployment across security, public safety, and healthcare sectors.
Astrotech (NASDAQ: ASTC) has announced the creation of a new wholly owned subsidiary, EN-SCAN, focused on manufacturing environmental testing instruments using proprietary ATi Gas Chromatograph and Astrotech Mass Spectrometer Technology.
The company will introduce three new products at PITTCON 2025 in Boston:
- EN-SCAN Rugged-Lab GC-MS: A transportable system for on-site analysis of air, water, and soil
- EN-SCAN Fenceline Monitor: A continuous emissions monitoring system for detecting pollutants like BTEX at refineries
- EN-SCAN Handheld GC: A portable device for detecting volatile organic compounds and contaminants
The product line is designed for outdoor field work, providing real-time analysis and instant feedback for contamination source location and migration in demanding environments.
Astrotech (NASDAQ: ASTC) reported Q2 FY2025 financial results with revenue of $295 thousand, primarily from activities with the U.S. Department of Homeland Security (DHS) for the TRACER 1000™ explosives trace detection system. The company maintains a strong balance sheet with $24.7 million in cash and liquid investments.
Key developments include a new R&D contract (70RSAT24CB0000015) with DHS for the TRACER 1000 and a purchase order from Intuitive Research and Technology , a TSA contractor. The company's 1st Detect subsidiary has expanded its product line to include narcotics trace detection, particularly focusing on fentanyl identification, and introduced Pro-Control products for chemical manufacturing process optimization.
The TRACER 1000 has demonstrated success with four years of operational history in cargo warehouses across 14 countries, processing thousands of samples.
FAQ
What is the current stock price of Astrotech (ASTC)?
What is the market cap of Astrotech (ASTC)?
